Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.8624
H.R.8624: Protecting Access to Innovation During COVID–19 Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Oct. 16, 2020
- Latest Major Action Oct. 16, 2020
Bill Sponsor
Bill Cosponsors
6 (1 Democrat, 5 Republicans)
Bill Version
- Introduced in House - Oct. 16, 2020
Bill Summary
Protecting Access to Innovation During COVID-19 Act This bill allows the Centers for Medicare & Medicaid Services (CMS) to extend the duration of pass-through status (i.e., additional payment) for certain drugs and devices under the Medicare prospective payment system for hospital outpatient department services. Specifically, the CMS may extend the pass-through status of drugs and devices that received such status during the public health...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Oct. 16, 2020 |
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Oct. 16, 2020 |
Introduced in the House by Brad Wenstrup (R-Ohio) |